Alirocumab: Revision history

13 December 2016

• curprev 19:4119:41, 13 December 2016‎ Tarek Nafee talk contribs‎ 13,300 bytes +1,238‎ No edit summary Tag: Visual edit

18 August 2015

• curprev 22:1322:13, 18 August 2015‎ Becca Cohen talk contribs‎ 12,062 bytes +2,225‎ No edit summary

24 March 2015

• curprev 15:5915:59, 24 March 2015‎ Sergekorjian talk contribs‎ 9,837 bytes +1,305‎ →‎ODYSSEY - Long Term
• curprev 15:4315:43, 24 March 2015‎ Sergekorjian talk contribs‎ 8,532 bytes −26‎ →‎ODYSSEY - FH II
• curprev 15:4315:43, 24 March 2015‎ Sergekorjian talk contribs‎ 8,558 bytes +673‎ →‎ODYSSEY - FH I
• curprev 15:2615:26, 24 March 2015‎ Sergekorjian talk contribs‎ 7,885 bytes −28‎ →‎ODYSSEY - COMBO I
• curprev 15:2015:20, 24 March 2015‎ Sergekorjian talk contribs‎ 7,913 bytes +601‎ →‎ODYSSEY - COMBO II
• curprev 15:1915:19, 24 March 2015‎ Sergekorjian talk contribs‎ 7,312 bytes +777‎ →‎ODYSSEY - COMBO II

19 March 2015

• curprev 16:0116:01, 19 March 2015‎ Sergekorjian talk contribs‎ 6,535 bytes +138‎ →‎Phase III Trials
• curprev 15:5515:55, 19 March 2015‎ Sergekorjian talk contribs‎ 6,397 bytes 0‎ →‎Phase II Trials
• curprev 15:4415:44, 19 March 2015‎ Sergekorjian talk contribs‎ 6,397 bytes +1,326‎ →‎Safety and efficacy of atorvastatin with or without alirocumab in primary hypercholesterolemia (NCT 01288469)
• curprev 15:3415:34, 19 March 2015‎ Sergekorjian talk contribs‎ 5,071 bytes +15‎ →‎Safety and efficacy of atorvastatin with or without alirocumab in primary hypercholesterolemia
• curprev 15:3415:34, 19 March 2015‎ Sergekorjian talk contribs‎ 5,056 bytes +15‎ →‎Safety and efficacy in primary hypercholesterolemia with ongoing stable atorvastatin therapy
• curprev 15:3315:33, 19 March 2015‎ Sergekorjian talk contribs‎ 5,041 bytes +15‎ →‎Safety and efficacy in heterozygous familial hypercholesterolaemia with ongoing stable-dose statin with or without ezetimibe therapy
• curprev 15:3115:31, 19 March 2015‎ Sergekorjian talk contribs‎ 5,026 bytes +106‎ →‎Phase II Trials
• curprev 15:2815:28, 19 March 2015‎ Sergekorjian talk contribs‎ 4,920 bytes +13‎ →‎Safety and efficacy in heterozygous familial hypercholesterolaemia with ongoing stable-dose statin with or without ezetimibe therapy
• curprev 15:2815:28, 19 March 2015‎ Sergekorjian talk contribs‎ 4,907 bytes +1,724‎ →‎Phase II Trials
• curprev 15:1415:14, 19 March 2015‎ Sergekorjian talk contribs‎ 3,183 bytes +1,338‎ →‎Safety and efficacy in primary hypercholesterolemia with ongoing stable atorvastatin therapy
• curprev 13:3913:39, 19 March 2015‎ Sergekorjian talk contribs‎ 1,845 bytes +103‎ →‎Phase II Trials
• curprev 13:3113:31, 19 March 2015‎ Sergekorjian talk contribs‎ 1,742 bytes +638‎ →‎Properties
• curprev 13:2413:24, 19 March 2015‎ Sergekorjian talk contribs‎ 1,104 bytes +146‎ →‎Overview

10 November 2014

• curprev 16:4216:42, 10 November 2014‎ Sergekorjian talk contribs‎ 958 bytes +7‎ Undo revision 1040125 by Sergekorjian (talk)
• curprev 16:4116:41, 10 November 2014‎ Sergekorjian talk contribs‎ 951 bytes −7‎ No edit summary

29 September 2014

• curprev 20:0720:07, 29 September 2014‎ Sergekorjian talk contribs‎ 958 bytes +958‎ Created page with "__NOTOC__ File:Pharmacologic-interventions-for-PCSK9.jpg|250px|thumb|right|Pharmacologic interventions for PCSK9 <font size="1">''Adapted from Journal of the American Colle..."